See more : Light & Wonder, Inc. (LNW) Income Statement Analysis – Financial Results
Complete financial analysis of Globe Life Inc. (GL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Globe Life Inc., a leading company in the Insurance – Life industry within the Financial Services sector.
You may be interested
- Hyfusin Group Holdings Limited (8512.HK) Income Statement Analysis – Financial Results
- Taiba Investments Co. (4090.SR) Income Statement Analysis – Financial Results
- PAE Incorporated (PAEWW) Income Statement Analysis – Financial Results
- Lanzhou Lishang Guochao Industrial Group Co.,Ltd (600738.SS) Income Statement Analysis – Financial Results
- SANNO Co., Ltd. (3441.T) Income Statement Analysis – Financial Results
Globe Life Inc. (GL)
About Globe Life Inc.
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.45B | 5.21B | 5.11B | 4.74B | 4.53B | 4.30B | 4.16B | 3.93B | 3.77B | 3.96B | 3.77B | 3.59B | 3.38B | 3.37B | 3.22B | 3.33B | 3.49B | 3.42B | 3.13B | 3.07B | 2.93B | 2.74B | 2.71B | 2.52B | 2.23B | 2.16B | 2.28B | 2.21B | 2.07B | 1.92B | 2.18B | 2.05B | 1.93B | 1.80B | 1.63B | 1.66B | 1.59B | 1.56B | 1.37B |
| Cost of Revenue | 347.83M | 353.95M | 322.03M | 301.04M | 304.83M | 279.59M | 257.26M | 232.06M | 223.86M | 222.65M | 214.69M | 198.18M | 201.64M | 176.27M | 174.09M | 185.21M | 173.41M | 169.77M | 172.86M | 151.20M | 142.36M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 5.10B | 4.86B | 4.79B | 4.44B | 4.22B | 4.02B | 3.90B | 3.70B | 3.54B | 3.74B | 3.56B | 3.39B | 3.18B | 3.19B | 3.05B | 3.14B | 3.31B | 3.25B | 2.95B | 2.92B | 2.79B | 2.74B | 2.71B | 2.52B | 2.23B | 2.16B | 2.28B | 2.21B | 2.07B | 1.92B | 2.18B | 2.05B | 1.93B | 1.80B | 1.63B | 1.66B | 1.59B | 1.56B | 1.37B |
| Gross Profit Ratio | 93.61% | 93.21% | 93.70% | 93.65% | 93.27% | 93.50% | 93.81% | 94.10% | 94.06% | 94.38% | 94.31% | 94.48% | 94.03% | 94.77% | 94.60% | 94.43% | 95.03% | 95.04% | 94.47% | 95.08% | 95.14% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 331.90M | 334.99M | 301.90M | 286.84M | 304.83M | 280.00M | 257.00M | 232.00M | 214.86M | 212.16M | 204.54M | 187.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 9.40M | 10.00M | 9.80M | 9.50M | 29.29M | 9.30M | 9.30M | 9.70M | 8.00M | 6.00M | 16.00M | 124.13M | 125.33M | 131.13M | 145.98M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 331.90M | 334.99M | 301.90M | 286.84M | 304.83M | 280.00M | 257.00M | 232.00M | 214.86M | 212.16M | 204.54M | 187.01M | 124.13M | 125.33M | 131.13M | 145.98M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | -4.20B | -4.50B | -4.13B | -3.90B | 3.08B | 2.99B | 2.86B | 2.71B | 2.55B | 2.45B | 2.56B | 2.45B | 2.42B | 2.34B | 2.36B | 2.62B | 2.57B | 2.33B | -2.15B | 0.00 | 10.22M | -2.10B | -1.91B | -1.77B | -1.70B | -1.69B | -1.64B | -1.69B | -1.45B | -1.66B | -1.58B | -1.51B | -1.41B | -1.27B | -1.35B | -1.25B | -1.31B | -1.12B |
| Operating Expenses | 3.78B | -3.86B | -4.20B | -3.84B | -3.60B | 3.35B | 3.24B | 3.08B | 2.92B | 2.76B | 2.66B | 2.74B | 2.58B | 2.54B | 2.47B | 2.51B | 2.62B | 2.57B | 2.33B | -2.15B | 2.36B | 10.22M | -2.10B | -1.91B | -1.77B | -1.70B | -1.69B | -1.64B | -1.69B | -1.45B | -1.66B | -1.58B | -1.51B | -1.41B | -1.27B | -1.35B | -1.25B | -1.31B | -1.12B |
| Cost & Expenses | 49.94M | 4.31B | 4.20B | 3.84B | 3.60B | 3.44B | 3.33B | 3.16B | 3.00B | 3.19B | 3.01B | 2.82B | 2.62B | 2.59B | 2.62B | 2.67B | 2.69B | 2.65B | 2.39B | 2.35B | 2.27B | 2.15B | 2.11B | 1.95B | 1.82B | 1.71B | 1.77B | 1.71B | 1.64B | 1.54B | 240.10M | 1.35B | 1.26B | 1.18B | 1.07B | 40.80M | 32.30M | 17.70M | 16.00M |
| Interest Income | 0.00 | 90.40M | 83.49M | 86.70M | 84.31M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 102.32M | 90.40M | 83.49M | 86.70M | 84.31M | 90.00M | 85.00M | 83.00M | 76.64M | 76.13M | 80.46M | 80.51M | 77.91M | 75.53M | 69.93M | 63.23M | 67.56M | 73.14M | 60.93M | 56.50M | 49.95M | 28.59M | 44.51M | 54.49M | 52.34M | 56.33M | 71.86M | 73.61M | 80.99M | 76.36M | 67.30M | 55.70M | 50.20M | 46.20M | 48.10M | 40.80M | 32.30M | 17.70M | 16.00M |
| Depreciation & Amortization | 0.00 | 21.00M | 20.00M | 17.00M | 16.00M | 13.00M | 10.50M | 9.80M | 337.34M | -863.14M | 315.12M | 317.18M | 314.78M | 326.57M | 0.00 | 0.00 | 391.01M | 377.49M | 349.96M | 4.80M | 4.81M | 302.73M | 5.82M | 6.86M | 8.84M | 7.93M | 9.33M | 9.06M | 9.60M | 25.30M | 35.60M | 33.50M | 25.60M | 16.60M | 14.50M | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 0.00 | 0.00 | 1.02B | 0.00 | 0.00 | 966.75M | 925.68M | 865.38M | 850.83M | 0.00 | 849.99M | 846.51M | 808.49M | 860.10M | 651.61M | 729.49M | 868.67M | 851.91M | 797.26M | 782.10M | 714.01M | 390.93M | 612.81M | 614.22M | 469.46M | 463.04M | 81.23M | 574.66M | 391.37M | 101.70M | 102.90M | 89.20M | 75.80M | 62.80M | 62.60M | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | 0.00% | 19.11% | 17.82% | 18.90% | 20.54% | 22.16% | 21.93% | 22.01% | 22.67% | 21.56% | 22.36% | 23.58% | 24.67% | 25.21% | 20.95% | 21.78% | 36.00% | 35.78% | 36.55% | 25.23% | 24.22% | 33.30% | 22.64% | 24.41% | 21.08% | 21.46% | 26.17% | 26.05% | 18.93% | 25.74% | 25.42% | 24.21% | 23.16% | 22.62% | 23.21% | 18.89% | 21.38% | 15.98% | 18.08% |
| Operating Income | 1.32B | 996.71M | 911.17M | 895.36M | 929.87M | 953.70M | 1.46B | 539.59M | 516.29M | 854.59M | 528.47M | 529.32M | 518.34M | 522.29M | 675.13M | 724.49M | 864.37M | 846.71M | 792.46M | 770.20M | 430.14M | 383.44M | 606.99M | 607.36M | 460.62M | 455.10M | 588.10M | 565.61M | 381.77M | 469.62M | 518.30M | 462.00M | 422.10M | 389.80M | 364.60M | 314.40M | 340.10M | 248.60M | 247.30M |
| Operating Income Ratio | 24.18% | 19.11% | 17.82% | 18.90% | 20.54% | 22.16% | 35.09% | 13.72% | 13.71% | 21.56% | 14.01% | 14.75% | 15.35% | 15.51% | 20.95% | 21.78% | 24.79% | 24.75% | 25.35% | 25.08% | 14.68% | 14.00% | 22.42% | 24.14% | 20.68% | 21.09% | 25.77% | 25.64% | 18.47% | 24.43% | 23.79% | 22.57% | 21.84% | 21.70% | 22.32% | 18.89% | 21.38% | 15.98% | 18.08% |
| Total Other Income/Expenses | -122.72M | -110.26M | 167.43M | -101.24M | -102.95M | -3.39B | -627.62M | 232.65M | 249.89M | -88.43M | 234.65M | -83.46M | 237.33M | 256.27M | -78.63M | -174.98M | -68.50M | -79.03M | -75.88M | -62.50M | 222.96M | 200.89M | 601.43M | 562.96M | 402.41M | 446.99M | 207.81M | 495.13M | 428.18M | 205.74M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 1.19B | 906.31M | 912.39M | 896.68M | 931.28M | 864.00M | 831.00M | 772.00M | 766.19M | 778.47M | 763.13M | 765.99M | 755.67M | 778.57M | 605.19M | 661.26M | 796.81M | 773.57M | 731.52M | 720.80M | 658.94M | 584.32M | 601.43M | 562.96M | 402.41M | 446.99M | 509.39M | 495.13M | 428.18M | 386.92M | 1.20B | 1.05B | 989.40M | 895.00M | 813.80M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 21.92% | 17.38% | 17.84% | 18.93% | 20.57% | 20.07% | 20.00% | 19.62% | 20.34% | 19.64% | 20.23% | 21.34% | 22.37% | 23.12% | 18.78% | 19.88% | 22.85% | 22.61% | 23.40% | 23.47% | 22.48% | 21.34% | 22.22% | 22.38% | 18.07% | 20.71% | 22.32% | 22.45% | 20.71% | 20.13% | 55.27% | 51.53% | 51.18% | 49.82% | 49.82% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 223.51M | 166.61M | 167.43M | 164.91M | 170.40M | 162.00M | -628.00M | 233.00M | 249.89M | 235.53M | 234.65M | 236.67M | 237.33M | 256.27M | 200.24M | 209.00M | 269.27M | 254.94M | 236.13M | 245.10M | 225.01M | 197.04M | 205.97M | 190.84M | 134.32M | 154.34M | 178.49M | 180.62M | 157.54M | 124.32M | 153.10M | 140.80M | 125.40M | 114.40M | 105.20M | 93.50M | 107.30M | 25.90M | 66.20M |
| Net Income | 970.76M | 894.39M | 744.96M | 731.77M | 760.79M | 701.00M | 1.45B | 550.00M | 527.10M | 542.94M | 528.47M | 529.32M | 517.89M | 517.06M | 404.95M | 452.26M | 527.54M | 518.63M | 495.39M | 468.60M | 430.14M | 383.43M | 356.51M | 362.04M | 273.96M | 244.44M | 337.74M | 311.37M | 143.24M | 268.95M | 297.90M | 265.50M | 246.50M | 229.20M | 211.30M | 180.10M | 200.50M | 205.00M | 165.10M |
| Net Income Ratio | 17.82% | 17.15% | 14.57% | 15.45% | 16.80% | 16.29% | 34.99% | 13.98% | 14.00% | 13.69% | 14.01% | 14.75% | 15.33% | 15.35% | 12.57% | 13.59% | 15.13% | 15.16% | 15.85% | 15.26% | 14.68% | 14.00% | 13.17% | 14.39% | 12.30% | 11.33% | 14.80% | 14.12% | 6.93% | 13.99% | 13.67% | 12.97% | 12.75% | 12.76% | 12.93% | 10.82% | 12.61% | 13.18% | 12.07% |
| EPS | 10.21 | 7.55 | 7.30 | 6.90 | 6.97 | 6.22 | 12.50 | 4.58 | 4.21 | 4.15 | 3.84 | 3.65 | 3.19 | 2.83 | 2.17 | 2.28 | 2.49 | 2.31 | 2.10 | 1.89 | 1.67 | 1.42 | 1.28 | 1.26 | 0.95 | 0.81 | 1.08 | 0.97 | 0.44 | 0.08 | 0.90 | 0.81 | 0.72 | 0.66 | 0.60 | 0.46 | 0.44 | 0.42 | 0.35 |
| EPS Diluted | 10.07 | 7.47 | 7.22 | 6.82 | 6.83 | 6.08 | 12.22 | 4.49 | 4.16 | 4.09 | 3.79 | 3.60 | 3.14 | 2.80 | 2.17 | 2.27 | 2.45 | 2.28 | 2.08 | 1.86 | 1.66 | 1.41 | 1.27 | 1.25 | 0.94 | 0.80 | 1.08 | 0.97 | 0.44 | 0.08 | 0.90 | 0.81 | 0.72 | 0.66 | 0.60 | 0.46 | 0.44 | 0.42 | 0.35 |
| Weighted Avg Shares Out | 95.10M | 97.93M | 102.07M | 106.08M | 109.15M | 112.70M | 116.32M | 120.09M | 125.09M | 130.72M | 137.65M | 144.92M | 162.42M | 183.01M | 186.83M | 198.12M | 212.21M | 224.41M | 235.65M | 247.48M | 258.06M | 270.45M | 277.88M | 287.81M | 289.22M | 301.71M | 312.69M | 320.63M | 322.28M | 3.22B | 330.76M | 329.33M | 344.52M | 349.77M | 352.38M | 391.39M | 457.40M | 487.83M | 477.74M |
| Weighted Avg Shares Out (Dil) | 96.36M | 98.98M | 103.17M | 107.22M | 111.38M | 115.25M | 118.98M | 122.37M | 126.76M | 132.64M | 139.56M | 146.85M | 164.72M | 184.69M | 186.83M | 199.16M | 215.65M | 227.47M | 238.17M | 251.61M | 259.44M | 271.30M | 279.84M | 288.83M | 292.06M | 305.20M | 312.69M | 322.16M | 322.28M | 3.22B | 330.76M | 329.33M | 344.52M | 349.77M | 352.38M | 391.39M | 457.40M | 487.83M | 477.74M |
Lawsuit Update: Investors Who Lost Money With Shares of Globe Life Inc. (NYSE: GL) Should Contact the Shareholders Foundation
The Shareholders Foundation, Inc. announces an update in the lawsuit that is pending for certain investors in Globe Life Inc. (NYSE:GL) shares. Investors in NYSE: GL shares should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Should Value Investors Buy Globe Life (GL) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
Globe Life Inc. (GL) Q3 2024 Earnings Call Transcript
Globe Life Inc. (NYSE:GL ) Q3 2024 Earnings Conference Call October 24, 2024 11:00 AM ET Company Participants Stephen Mota - Senior Director-Investor Relations Frank Svoboda - Co-Chief Executive Officer Matt Darden - Co-Chief Executive Officer Thomas Kalmbach - Chief...
Globe Life Q3 Earnings Beat, Revenues Miss, Premiums Rise Y/Y
GL's third-quarter results reflect higher excess investment income and insurance underwriting income as well as growth in Life and Health insurance premiums.
Globe Life (GL) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Globe Life (GL) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago...
Globe Life (GL) Q3 Earnings Surpass Estimates
Globe Life (GL) came out with quarterly earnings of $3.49 per share, beating the Zacks Consensus Estimate of $3.05 per share. This compares to earnings of $2.71 per share a year ago.
GLOBE LIFE INC. REPORTS THIRD QUARTER 2024 RESULTS
MCKINNEY, Texas , Oct. 23, 2024 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended September 30, 2024, net income was $3.44 per diluted common share, compared with $2.68 per diluted common share for the year-ago...
INVESTOR ALERT: Rigrodsky Law, P.A. Is Investigating Globe Life Inc. On Behalf of Shareholders
WILMINGTON, DE / ACCESSWIRE / October 21, 2024 / Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Globe Life Inc. ("Globe Life" or the "Company") (NYSE:GL) on behalf of stockholders.
Insights Into Globe Life (GL) Q3: Wall Street Projections for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Globe Life (GL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
Globe Life targeted by ‘unknown threat actor' in extortion attempt
Globe Life Inc. has been targeted in an extortion attempt, the life insurance company revealed Thursday.
Source: https://incomestatements.info
Category: Stock Reports